Comparing the Effectiveness of a Treat-to-target (T2T) Disease Management Strategy vs. Routine Care (RC) in Adult Patients With Moderate to Severe Rheumatoid Arthritis (RA) Treated With Subcutaneous Abatacept (Orencia - SC) - IM101-331
Updated: 28 January, 2019 | ClinicalTrials.gov
This clinical trial is now complete.
For clinical trial results please visit ClinicalTrials.gov.